129 related articles for article (PubMed ID: 29803727)
1. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis.
Lu VM; Goyal A; Vaughan LS; McDonald KL
Clin Neurol Neurosurg; 2018 Jul; 170():165-169. PubMed ID: 29803727
[TBL] [Abstract][Full Text] [Related]
2. The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.
Lu VM; Jue TR; McDonald KL; Rovin RA
World Neurosurg; 2018 Jul; 115():453-459.e3. PubMed ID: 29654958
[TBL] [Abstract][Full Text] [Related]
3. Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis.
Lu VM; Jue TR; Phan K; McDonald KL
Clin Neurol Neurosurg; 2018 Jan; 164():75-80. PubMed ID: 29202377
[TBL] [Abstract][Full Text] [Related]
4. The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis.
Lu VM; Texakalidis P; McDonald KL; Mekary RA; Smith TR
Clin Neurol Neurosurg; 2018 Nov; 174():149-155. PubMed ID: 30243186
[TBL] [Abstract][Full Text] [Related]
5. Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.
Lu VM; Goyal A; Graffeo CS; Perry A; Burns TC; Parney IF; Quinones-Hinojosa A; Chaichana KL
World Neurosurg; 2019 Jul; 127():31-37. PubMed ID: 30947000
[TBL] [Abstract][Full Text] [Related]
6. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
Lu VM; Alvi MA; McDonald KL; Daniels DJ
J Neurosurg Pediatr; 2018 Nov; 23(3):308-316. PubMed ID: 30544362
[TBL] [Abstract][Full Text] [Related]
7. Metformin influences progression in diabetic glioblastoma patients.
Adeberg S; Bernhardt D; Ben Harrabi S; Bostel T; Mohr A; Koelsche C; Diehl C; Rieken S; Debus J
Strahlenther Onkol; 2015 Dec; 191(12):928-35. PubMed ID: 26329695
[TBL] [Abstract][Full Text] [Related]
8. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
9. The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma.
Adeberg S; Bernhardt D; Foerster R; Bostel T; Koerber SA; Mohr A; Koelsche C; Rieken S; Debus J
Acta Oncol; 2016; 55(2):201-7. PubMed ID: 25990634
[TBL] [Abstract][Full Text] [Related]
10. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract][Full Text] [Related]
11. MGMT promoter methylation and glioblastoma prognosis: a systematic review and meta-analysis.
Chen Y; Hu F; Zhou Y; Chen W; Shao H; Zhang Y
Arch Med Res; 2013 May; 44(4):281-90. PubMed ID: 23608672
[TBL] [Abstract][Full Text] [Related]
12. Ten-year survival in glioblastoma. A systematic review.
Tykocki T; Eltayeb M
J Clin Neurosci; 2018 Aug; 54():7-13. PubMed ID: 29801989
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
14. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
Mistry AM; Hale AT; Chambless LB; Weaver KD; Thompson RC; Ihrie RA
J Neurooncol; 2017 Jan; 131(1):125-133. PubMed ID: 27644688
[TBL] [Abstract][Full Text] [Related]
15. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
16. Age alone is not a predictor for survival in glioblastoma.
Gately L; Collins A; Murphy M; Dowling A
J Neurooncol; 2016 Sep; 129(3):479-485. PubMed ID: 27406585
[TBL] [Abstract][Full Text] [Related]
17. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
[TBL] [Abstract][Full Text] [Related]
19. Association Between Perioperative Hyperglycemia and Survival in Patients With Glioblastoma.
Hagan K; Bhavsar S; Arunkumar R; Grasu R; Dang A; Carlson R; Cowles C; Arnold B; Potylchansky Y; Rahlfs TF; Lipski I; Walsh C; Jimenez F; Nguyen AT; Feng L; Cata JP
J Neurosurg Anesthesiol; 2017 Jan; 29(1):21-29. PubMed ID: 27438798
[TBL] [Abstract][Full Text] [Related]
20. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
